摘要
目的 观察依达拉奉联合舒血宁注射液辅治急性脑梗死的临床效果。方法 将60例急性脑梗死患者随机分为治疗组与对照组各30例。对照组应用常规治疗,而治疗组另加用依达拉奉和舒血宁注射液辅治,连用14d。观察2组临床疗效和治疗前后神经功能缺损(NIHSS)评分。结果 治疗组总有效率为93.3%高于对照组的70.0%,差异有统计学意义(P<0.05)。治疗前2组NIHSS评分差异无统计学意义(P>0.05),治疗后2组均低于治疗前,且治疗组低于对照组,差异均有统计学意义(P<0.05)。结论 依达拉奉联合舒血宁注射液辅治急性脑梗死,可显著改善脑梗死患者预后,疗效显著,值得临床推广应用。
Objective To observe the clinical effect of edaravone combined with shuxuening injection in acute cere -bralinfarction.Methods 30casesacutecerebralinfarctionwererandomlydividedintotreatmentgroupandcontrolgroup,each of 15 cases.Control group adopted conventional treatment ,Treatment group was treated by edaravone combined with shuxuening injection.After treatment,compared the clinical effect and neurological deficits before and after treatment of 2 groups.Results The total efficiency of treatment group （93.3%）was higher than that before control group （70.0%）,the difference was sta-tistically significant（P〈0.05）.The level of NIHSS score of 2 groups before treatment has no statistically significant （P〉0.05）.The level of NIHSS score of 2 groups after treatment was lower than that before treatment （P〈0.05）,and the level of NIHSS score of treatment group was higher than that of control group （P〈0.05）.Conclusion Edaravone combined with shuxuening injection in acute cerebral infarction has an good effect ,can significantly improve the prognosis of patients with cer-ebral infarction worthy of clinical appliation .
出处
《临床合理用药杂志》
2015年第19期3-4,共2页
Chinese Journal of Clinical Rational Drug Use
